BMY
Bristol-Myers Squibb Company
Stock
$61.15−0.31 (−0.50%)Close Oct 2, 2026
- Stock-based compensation, 2025
- $553M
- YoY, 2025
- +9.1%
- 5-year CAGR
- −6.6%
- 10-year CAGR
- +8.9%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $553M | +9.1% |
| 2024 | $507M | −2.1% |
| 2023 | $518M | +13.3% |
| 2022 | $457M | −21.6% |
| 2021 | $583M | −25.2% |
| 2020 | $779M | +76.6% |
| 2019 | $441M | +99.5% |
| 2018 | $221M | +11.1% |
| 2017 | $199M | −2.9% |
| 2016 | $205M | −12.8% |
| 2015 | $235M | +10.3% |
| 2014 | $213M | +11.5% |
| 2013 | $191M | +24.0% |
| 2012 | $154M | −4.3% |
| 2011 | $161M | −16.6% |
| 2010 | $193M | +5.5% |
| 2009 | $183M | +1.1% |
| 2008 | $181M | +36.1% |
| 2007 | $133M | — |